Deferred Tax Assets, Operating Loss Carryforwards of REGENEREX PHARMA, INC. from 30 Nov 2013 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
REGENEREX PHARMA, INC. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 30 Nov 2013 to 31 Mar 2025.
  • REGENEREX PHARMA, INC. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Mar 2025 was $921,217, a 98% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

REGENEREX PHARMA, INC. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $921,217 +$457,117 +98% 31 Mar 2025 10-K 30 Jun 2025 2024 FY
Q1 2024 $464,100 +$118,300 +34% 31 Mar 2024 10-K 30 Jun 2025 2024 FY
Q1 2023 $345,800 +$31,600 +10% 31 Mar 2023 10-K 24 Jun 2024 2023 FY
Q1 2022 $314,200 +$83,200 +36% 31 Mar 2022 10-K 09 Jun 2023 2023 FY
Q1 2021 $231,000 -$28,000 -11% 31 Mar 2021 10-K 23 Jun 2021 2020 FY
Q1 2020 $259,000 +$20,000 +8.4% 31 Mar 2020 10-K 23 Jun 2021 2020 FY
Q1 2019 $239,000 +$8,000 +3.5% 31 Mar 2019 10-K/A 11 Aug 2020 2019 FY
Q1 2018 $231,000 -$141,000 -38% 31 Mar 2018 10-K 24 Jun 2019 2018 FY
Q1 2017 $372,000 31 Mar 2017 10-K 21 Jun 2018 2017 FY
Q4 2014 $374,878 -$316,690 -46% 30 Nov 2014 10-K 03 Mar 2015 2014 FY
Q3 2014 $356,437 31 Aug 2014 10-Q 20 Oct 2014 2014 Q3
Q4 2013 $691,568 30 Nov 2013 10-K 03 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.